POCT Co-oximetry
[POCT Co-oximetry]
EPTIS Ringversuch Nr. 1144033 | Letze Änderung 2024-05-22 | URL: https://www.eptis.bam.de/pts1144033 https://www.eptis.bam.de/pts1144033
| Name des Anbieters | ||||||||||||||||
| Name des Anbieters | Weqas Weqas | |||||||||||||||
| Ansässig in | United Kingdom | |||||||||||||||
| Sprache(n) | ||||||||||||||||
| Anmerkungen | The material is a blood-based matrix containing the 4 major haemoglobin derivates, and unlike dyes provided by other EQA providers, it has equivalent spectral properties to whole blood. Compatible with all major Co-oximeters. Panel covers clinically relevant ranges. Packaged in an easy to use dual-chambered vial that separates the oxyhemoglobin from methemoglobin to enhance stability. Three aqueous samples are distributed monthly, with a minimum of 33 samples distributed over the year, covering a wide clinically relevant range. The samples consist of a panel of 6 linearly related samples distributed on a number of occasions over that period, which are used to assess both laboratory and method performance, including linearity, bias, and within and between batch imprecision. Key Features: Panel covers clinically relevant range. Easy to use vials with minimal preparation time. Material contains the 4 major haemoglobin derivates and unlike dyes has equivalent spectral properties to whole blood. Compatible with all major Cooximeters. For more information: https://www.weqas.com/services/poct-eqa/poct-co-oximetry/ or contact@weqas.com | |||||||||||||||
| Klassifizierung | ||||||||||||||||
| Produktgruppen |
Health care / medical devices
|
|||||||||||||||
| Prüfgebiete |
Medical analysis
|
|||||||||||||||
| Technische Einzelheiten | ||||||||||||||||
|
||||||||||||||||
| Ringversuchsziele | ||||||||||||||||
| Zielgruppe des Ringversuchs | The Programme aims to assess the performance of organisations utilising blood gas analysers for the analysis of the patients’ haemoglobin and co-oximetry status. The Programme is available to both Laboratory and Point of Care testing sites and is part of the Blood Gas and Co-oximetry Programme offering the complete repertoire of blood gas analytes including calculated parameters, electrolytes, metabolites and Co-oximetry. | |||||||||||||||
| Relevante Rechtsvorschriften oder Normen | ISO/IEC 17043 | |||||||||||||||
| Weitere Ziele | validation of testing methods | |||||||||||||||
| Teilnehmerzahl | ||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch UKAS auf der Grundlage von ISO/IEC 17043 |
|||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | ||||||||||||||||
| Kosten | ||||||||||||||||
| Teilnahmegebühr | https://www.weqas.com/participantzone/subscription-charges/ | |||||||||||||||
| Regelmässig durchgeführt | Ja (Frequency: Bimonthly. Samples: 3 x 2.0mL. ) | |||||||||||||||
| Der Ringversuch wird durchgeführt seit | 1994 | |||||||||||||||
| Kontaktdaten des Anbieters | ||||||||||||||||
| Anbieter | Kontaktperson | |||||||||||||||
|
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Telefon: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Telefon: 44 (0) 29218 32884 Fax: E-Mail: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
|||||||||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.